$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push 
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 
DeepSeek Slashes AI Model Pricing to Boost Adoption and Challenge Global Rivals 
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips 
Daiichi Sankyo Stock Drops After Earnings Delay and Oncology Review 
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases 
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions 
Nomura Shares Drop After Profit Miss Despite Strong Revenue Growth 
U.S. Raises Alarm Over Chinese AI Firms’ Alleged IP Theft Through Model Distillation 
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules 
Mercedes-Benz Faces Rising Competition in China but Rejects Price War Strategy 
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure 
Kia Cuts EV Prices in Europe as Chinese Carmakers Intensify Competition 
NAPLES, Fla., May 10, 2017 -- HealthLynked Corp. (OTCQB:HLYK) today announced that it has commenced trading on the OTCQB under the symbol “HLYK”. The Company plans to release its first quarter 2017 financial results on Monday, May 15, 2017.
Dr. Michael Dent, Chairman and Chief Executive Officer stated, “Our shareholders have patiently waited for HealthLynked to become a publicly traded company and today, that becomes a reality. We appreciate their support and belief in our mission to improve healthcare.”
He continued, “I am thrilled about the recent addition to our management team of Rob Horel, our Chief Commercial Officer and former VP of Sales and Marketing at NeoGenomics to lead our sales and marketing initiatives for HealthLynked. Mr. Horel has already hired our first round of sales executives and will be leading the sales training program later this month. We are expecting great things from Mr. Horel and his sales team as we plan to launch the HealthLynked Network next month. I am excited about the future of HealthLynked and what we will be offering to the healthcare market.”
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and healthcare providers to improve healthcare. The HealthLynked Network is a cloud-based platform that allows patients to enter their medical history, medications, allergies, past surgeries and medical records in one convenient online secure location, free of charge.
Participating healthcare providers realize benefits in the ability to see more patients, access more accurate patient information, participate in our telemedicine program, improve patient retention and increase online filing of vacancies including last minute cancelations through our “real time appointment scheduling” mobile application. Healthcare providers pay a monthly fee to increase online visibility, recruit new patients, and improve office efficiency.
For additional information about HealthLynked Corp. visit www.healthlynked.com
Forward Looking Statements
Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements. These forward looking statements involve a number of risks and uncertainties that could cause actual future results to differ materially from those anticipated in the forward looking statements, Actual results could differ materially from such statements expressed or implied herein. Factors that might cause such a difference include, among others, the company's ability to gain new customers, offer new types of services, and otherwise implement its business plan. As a result, this press release should be read in conjunction with the company's filings with the SEC.
Company Contact: George O’Leary Chief Financial Officer [email protected] Investor Relations contact: Amato and Partners, LLC Investor Relations Counsel [email protected]
